Ki67 drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (8)
Papers in which this entity is mentioned.
- Desmoplastic stromal signatures predict patient outcomes in pancreatic ductal adenocarcinoma. (2023)
- B cells and tertiary lymphoid structures promote immunotherapy response. (2020)
- Orthotopic patient-derived xenografts of paediatric solid tumours. (2017)
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. (2016)
- Comprehensive genomic profiles of small cell lung cancer. (2015)
- CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma. (2014)
- PVT1 dependence in cancer with MYC copy-number increase. (2014)
- LIN28B promotes growth and tumorigenesis of the intestinal epithelium via Let-7. (2013)
Merged raw entities (6)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| ki67 | gene | 24 | 42 |
| ki67 | drug | 12 | 37 |
| ki-67 | drug | 6 | 6 |
| ki67+ cells | drug | — | — |
| ki67-ir | drug | — | — |
| mki67 | drug | — | — |